Femtrace Side Effects
Generic Name: Estradiol
Please note - some side effects for Femtrace may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
|
For the consumer For the professional
|
|
Side Effects of Femtrace - for the consumer
Femtrace
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Femtrace:
Seek medical attention right away if any of these SEVERE side effects occur when using Femtrace:Abnormal hair growth; breast tenderness; changes in sex drive; cramps; dizziness; flushing; hair loss; headache; lightheadedness; nausea; stomach bloating and upset; swelling.
TopSevere allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); abnormal vaginal bleeding; breast lumps; changes in vaginal bleeding (eg, spotting, breakthrough bleeding, prolonged bleeding); changes in speech; coughing of blood; mental/mood changes (eg, severe depression, memory loss); migraine headache; pain in calves or chest; pain, swelling, or tenderness in the stomach; severe headache or vomiting; sudden shortness of breath; swelling of hands or feet; unusual vaginal discharge, itching, or odor; vision changes (eg, double vision, changes in contact lens fit, loss of vision); weakness or numbness of an arm or leg; weight changes; yellowing of the skin or eyes.
For the professional
Femtrace
See BOXED WARNINGS, WARNINGS and PRECAUTIONS.
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. The adverse reaction information from clinical trials does, however, provide a basis for identifying the adverse events that appear to be related to drug use and for approximating rates.
In two 12-week clinical trials that included 327 postmenopausal women treated with Femtrace and 221 women treated with placebo tablets, adverse events that occurred in any treatment group at a rate of ≥ 2% regardless of drug relationship are summarized in Table 5. Incidence of AEs Occurring in ≥ 2% of Subjects in Any Treatment Group Presented in Descending Frequency of Preferred Term .
| ||||
| Adverse Event* | Placebo |
Femtrace |
Femtrace |
Femtrace |
| n (%) | n (%) | n (%) | n (%) | |
| Headache (NOS) | 12 (5.4) | 4 (3.0) | 5 (5.0) | 4 (4.2) |
| Vaginal Bleeding | 3 (1.4) | 1 (0.8) | 4 (4.0) | 7 (7.4) |
| Breast Tenderness | 3 (1.4) | 1 (0.8) | 0 (0.0) | 6 (6.3) |
| Influenza | 3 (1.4) | 3 (2.3) | 0 (0.0) | 4 (4.2) |
| Vaginal Discharge | 0 (0.0) | 3 (2.3) | 4 (4.0) | 3 (3.2) |
| Abdominal Pain (NOS) | 4 (1.8) | 1 (0.8) | 0 (0.0) | 3 (3.2) |
| Fungal Infection (NOS) | 2 (0.9) | 4 (3.0) | 1 (1.0) | 1 (1.1) |
| Nasopharyngitis | 5 (2.3) | 2 (1.5) | 0 (0.0) | 1 (1.1) |
| Nausea | 3 (1.4) | 3 (2.3) | 0 (0.0) | 2 (2.1) |
| Intermenstrual Bleeding | 2 (0.9) | 0 (0.0) | 2 (2.0) | 3 (3.2) |
| Sinusitis (NOS) | 3 (1.4) | 2 (1.5) | 1 (1.0) | 1 (1.1) |
| Upper Respiratory Tract Infection (NOS) | 3 (1.4) | 1 (0.8) | 3 (3.0) | 0 (0.0) |
| Back Pain | 1 (0.5) | 0 (0.0) | 3 (3.0) | 2 (2.1) |
| Bronchitis (NOS) | 1 (0.5) | 2 (1.5) | 2 (2.0) | 1 (1.1) |
AE = adverse event; NOS = not otherwise specified | ||||
The following additional adverse reactions have been reported with estrogen and/or progestin therapy.
1. Genitourinary system
Changes in vaginal bleeding pattern and abnormal withdrawal bleeding or flow; breakthrough bleeding; spotting; dysmenorrhea; increase in size of uterine leiomyomata; vaginitis including vaginal candidiasis; change in amount of cervical secretion; changes in cervical ectropion; ovarian cancer; endometrial hyperplasia; endometrial cancer.
2. Breasts
Enlargement, pain, nipple discharge, galactorrhea; fibrocystic breast changes; breast cancer.
3. Cardiovascular
Deep and superficial venous thrombosis; pulmonary embolism; thrombophlebitis; myocardial infarction; stroke; increase in blood pressure.
4. Gastrointestinal
Vomiting, abdominal cramps, bloating; cholestatic jaundice; increased incidence of gallbladder disease; pancreatitis; enlargement of hepatic hemangiomas.
5. Skin
Chloasma or melasma that may persist when drug is discontinued; erythema multiforme; erythema nodosum; hemorrhagic eruption; loss of scalp hair; hirsutism; pruritis, rash.
6. Eyes
Retinal vascular thrombosis; intolerance to contact lenses.
7. Central nervous system
Migraine; dizziness; mental depression; chorea; nervousness; mood disturbances; irritability; exacerbation of epilepsy, dementia.
8. Miscellaneous
Increase or decrease in weight; reduced carbohydrate tolerance; aggravation of porphyria; edema; arthralgias; leg cramps; changes in libido; urticaria; angioedema; anaphylactoid/anaphylactic reactions; hypocalcemia; exacerbation of asthma; increased triglycerides.
TopMore resources:
Alora - Includes detailed dosage instructions.
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
